类风湿关节炎传统药物和生物制剂的安全性。
Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
作者信息
Amoroso A, Gigante A, Gianni C, Amoroso D, Zennaro D, Galluzzo S, Caccavo D
机构信息
Dpt. of Clinical Medicine, University of Rome La Sapienza, Italy.
出版信息
Eur Rev Med Pharmacol Sci. 2003 Sep-Oct;7(5):139-45.
PMID:15214589
Abstract
While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).
摘要
虽然初步研究表明，服用生物制剂的类风湿性关节炎（RA）患者与接受传统治疗的患者相比症状有所减轻，但这些药物的安全性仍然令人担忧。本文的作者回顾了使用生物制剂的类风湿性关节炎新治疗方法的安全性，并将其与传统抗风湿药物（DMARDs）的安全性进行了比较。
Zotero 插件